Replies to post #48929 on Ariad Pharmaceuticals Inc fka ARIA

[dummey]

Ariad Pharmaceuticals (NASDAQ: ARIA) shares rose 2.77% to $7.43 after Jefferies upgraded the stock from Neutral to Outperform and lifted the price target from $8.00 to $14.00.

Read more: http://www.benzinga.com/news/14/05/4525591/morning-market-movers#ixzz30qozFaP7